Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: pegylated liposomal doxorubicin hydrochloride|DRUG: cyclophosphamide|BIOLOGICAL: trastuzumab
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)